Article Information
History
- July 31, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Lisa Seekircher1,†,
- Anita Siller2,†,
- Manfred Astl2,
- Lena Tschiderer1,3,
- Gregor A. Wachter2,
- Bernhard Pfeifer4,5,
- Andreas Huber4,
- Manfred Gaber6,
- Harald Schennach2,*,‡ and
- Peter Willeit1,7,*,‡
- 1Clinical Epidemiology Team, Medical University of Innsbruck, 6020 Innsbruck, Austria
- 2Central Institute for Blood Transfusion and Immunology, Tirol Kliniken GmbH, 6020 Innsbruck, Austria
- 3Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
- 4Tyrolean Federal Institute for Integrated Care, Tirol Kliniken GmbH, 6020 Innsbruck, Austria
- 5Division for Healthcare Network and Telehealth, UMIT-Private University for Health Sciences, Medical Informatics and Technology GmbH, 6060 Hall, Austria
- 6Blood donor service Tyrol of the Austrian Red Cross, 6063 Rum, Austria
- 7Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK
- ↵‡Corresponding authors:
Univ.-Prof. Dr. Peter Willeit MPhil PhD (peter.willeit{at}i-med.ac.at) and Univ.-Doz. Dr. Harald Schennach (harald.schennach{at}tirol-kliniken.at)
Posted July 31, 2022.
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Tyrol, Austria: Updated analysis involving 22,607 blood donors covering the period October 2021 to April 2022
